ENHANC3D GENOMICS

✨NEW Video Drop: A 2-minute journey into 3D Genomics ✨ 🧬We're not just reading the book of life - we're unlocking its secrets like never before. Learn how our 3D Genome Atlas is set to transform drug discovery in this new animated video. 👏Special thanks to the team at Reciprocal Space for helping turn our vision into reality. 🔗Intrigued by 3D genomics? Explore our technology: https://lnkd.in/dQ-mFdS5 #3DGenomics #DrugDiscovery #BioTech

This month, we caught up with our Business Development Manager, Kishen Chahwala, PhD! 👉 Swipe to learn how he's shaping the future of biotech through strategic partnerships and scientific innovation. 🧬 #EmployeeSpotlight #BiotechInnovation #LifeSciences

Excited to announce that our CEO, Hazel Jones, will be speaking at the Biotech Pioneers Leadership Summit on 26 November 2024 at IDEALondon! Register here: https://lnkd.in/ezm7iFER #bpls2024 #biotechleadership

This week's trio of news and views from the St John's Innovation Park community: - ENHANC3D GENOMICS' (based in The Jeffreys Building) CEO Hazel Jones spoke to the Cambridge Independent newspaper about the company's tech, science, and fast progress: https://ow.ly/A9z850TQtNG - The #AutumnBudget will be delivered tomorrow (30 October 2024). What can we expect? Hear predictions from the experts at RSM UK including thoughts on business tax and the growth agenda: https://ow.ly/jIPP50TNxiI - Co-founder and former CEO of SJIP-based AI cyber-security company Darktrace, Poppy Gustafsson, has been appointed as the UK’s Investment Minister: https://ow.ly/vfWv50TNwok #Cambridge #UK #Tech #Investment #Genomics #CEO

Celebrating One Year of Visionary Leadership!🎉 ENHANC3D GENOMICS recently celebrated Hazel's one year work anniversary. Hazel joined the company as Chief Operating Officer and was made CEO in May. In a short space of time, Hazel's innovative vision and strategic leadership have propelled our company to new heights in the biotech industry. Hazel's commitment to fostering a culture of innovation, inclusivity, and scientific excellence has been instrumental in our success. Her dedication to improving patient outcomes through cutting-edge biotechnology continues to inspire us all. We're excited for the future and look forward to many more years of transformative innovations under Hazel's guidance. Join us in congratulating Hazel on this milestone! #BiotechLeadership #InnovationInHealthcare #CompanyAnniversary

Our first session of our new Virtual Seminar Series, 'The 3D Regulatory Genome' is fast approaching! Join us for an exciting seminar with guest speaker Dr Pradeepa Madapura from the Blizard Institute. 📅 November 7, 2024 ⏰ 16:00 GMT 📍 Virtual (Zoom link sent upon registration) Join our 3D Genomics Professional Network to register: https://lnkd.in/eitEtkfj #VirtualSeminar #Genomics #3DGenomeOrganisation #EnhancerRoles

Our BD Manager, Dr Kishen Chahwala, PhD and CEO, Dr Hazel Jones just wrapped up an incredibly productive experience at the BioTechX conference in Basel! It was great to build new connections and reconnect with familiar faces in the industry. The buzz around AI was palpable, and it's fascinating to see how pharmaceutical companies are pivoting to harness the full potential of AI innovations. The landscape of drug discovery and development is evolving rapidly, and we're thrilled to be at the forefront of this revolution. A highlight of the conference was Hazel's presentation on our cutting-edge platform technology. Her talk showcased how we're revolutionising drug discovery by integrating 3D genomic and multiomic data, providing unprecedented insights into disease mechanisms and potential therapeutic targets. Looking forward to building on the momentum from this conference and exploring new collaborations. The future of biotech is bright, and we're excited to play our part in shaping it. #BioTechX #AIinPharma #DrugDiscovery #Biotechnology #Innovation

🔬The results are in!📊 Our poll shows healthcare (51%) and biotechnology (49%) neck-and-neck when asked which sector will gain the most from 3D genomics research. This reflects how deeply intertwined these sectors have become in advancing genomic innovations. 🧬 #3DGenomics #Biotech #Healthcare #Innovation #LifeSciences #Genomics #Research #BiotechInnovation

We're thrilled to share some exciting updates from last week's BIA TechBio conference! Our CEO, Dr Hazel Jones had the opportunity to showcase our ground-breaking work in accelerating target identification. Key Highlights: 🚀Our case studies demonstrated that target identification becomes 50 times faster when combining a specific cell-type 3D profile with a disease GWAS study. 💬The presentation sparked engaging discussions and valuable insights from industry peers. We'd like to extend our gratitude to the BioIndustry Association (BIA) for organising this fantastic event and to all attendees for their thoughtful engagement. Stay tuned for more innovations as we continue to push the boundaries of genomic research! #TechBioUK #GenomicResearch #DrugDiscovery #BioTech

Exciting news! Our Chief Scientific Officer, Dr Dan Turner, will be presenting a poster at the American Society of Human Genetics (ASHG) Annual Meeting! Dan will showcase our ground-breaking research in multiomics and its applications in personalised medicine and drug discovery. This work represents a significant step forward in our mission to revolutionise patient care and accelerate drug development through advanced genetic analysis. We invite all ASHG attendees to visit Dan's poster on November 8th and engage in discussions about this innovative work. Your insights and feedback are invaluable as we continue to push the boundaries of genetic research and its real-world applications. Can't make it to ASHG? Follow us on LinkedIn for updates and key takeaways from the conference. #ASHG2023 #Genetics #Biotechnology #Multiomics #PersonalisedMedicine #DrugDiscovery